CBC (Cannabichromene) - The New Star in the Cannabinoid Sky?

CBC (Cannabichromene) is currently on everyone's lips. As one of over 100 cannabinoids in the hemp plant (Cannabis sativa), it long stood in the shadow of its better-known siblings THC and CBD – yet CBC was actually discovered by the same researchers who first isolated THC.

That is changing now. With the increasing spread of cannabis products, more and more consumers are specifically looking for certain effects. CBC could indeed turn out to be one of the most interesting active ingredients of the cannabis plant and help to further expand its potential uses.

But what properties and possible effects of CBC actually make it so interesting? What does current research say about it and why is CBC so much more expensive than CBD? This article explains it to you!

CBC was discovered as early as 1966 by researchers Yehiel Gaoni and Raphael Mechoulam; the same researchers who first isolated THC. (1) Nevertheless, CBC led a rather shadowy existence for years. Only in recent years – certainly also due to legalization in various countries – has interest in cannabinoids other than THC and CBD also increased.

Because: Researchers have now recognized that even the lesser-known cannabinoids may have properties that make them ideal for the treatment of certain diseases and symptoms. CBC is particularly exciting here because it works completely differently than its more famous relatives.

Cannabichromene (CBC) is a phytocannabinoid that occurs naturally in the cannabis plant. It is formed, similar to THC and CBD, from the precursor substance CBG/CBGa (cannabigerol/cannabigerolic acid). CBGa is converted into various cannabinoids in a complex process, depending on which enzymes become active in the plant. In the case of CBC, CBCa (cannabichromenic acid) is initially formed, which is then decarboxylated to CBC by heat or UV light.

A central peculiarity of CBC: It occurs mainly in young hemp plants. As the plant matures, the concentration of CBC decreases, while other cannabinoids increase. It is believed that this has evolutionary reasons: CBCa and CBC particularly well protect the young plant from UV radiation and diseases/pests. Later, other substances are more needed.

A central peculiarity of CBC: It occurs mainly in young hemp plants. As the plant matures, the concentration of CBC decreases, while other cannabinoids increase. It is believed that this has evolutionary reasons: CBCa and CBC particularly well protect the young plant from UV radiation and diseases/pests. Later, other substances are more needed.

• Anti-inflammatory – can reduce inflammation

• Pain-relieving – supports pain-relieving effects, especially with THC

• Neurogenesis – promotes the growth of new brain cells

• Mood-lifting – potentially antidepressant & stress-reducing

• Entourage effect – enhances the effect of other cannabinoids

• Skin health – regulates sebum, acts against acne & skin inflammation

Anyone who has even a little knowledge of cannabinoids will notice: The interest in CBC and other cannabinoids beyond THC and CBD is currently very high. This has various causes.

One of the main reasons is certainly the growing awareness that many effects of cannabis are not only due to individual cannabinoids, but to a complex interplay. The so-called entourage effect ensures that various cannabinoids, terpenes, and other plant substances in the hemp plant influence each other and enhance their effects (or, in the case of THC, mitigate psychoactive effects).

But the properties and effects of CBC itself are also coming into focus.

CBC differs quite strongly from THC and CBD. While THC primarily binds to cannabinoid receptors in the brain and thus has, among other things, psychoactive effects, and CBD modulates these receptors, CBC works completely differently. It binds only weakly to the classic cannabinoid receptors CB1 and CB2, but instead interacts with other receptors in the endocannabinoid system (ECS).

Research has shown that CBC interacts particularly with TRPV1 receptors (so-called vanilloid receptors). (2) These receptors are, among other things, crucial for pain perception. In addition, CBC also appears to interact with TRPA1 receptors, which also play an important role in pain processing. This suggests that CBC could be particularly effective for certain types of pain, especially neuropathic pain, which is often difficult to treat otherwise.

In addition to pain treatment, CBC could inhibit inflammation in a different way than CBD - and thus be more effective for certain diseases. CBC also shows great potential for depression: animal studies have shown that CBC could positively influence mood, without sedative effects or other unwanted side effects. (3)

Particularly exciting: A preclinical study from 2013 showed that CBC may promote neurogenesis, i.e. the formation of new nerve cells in the brain. (4) This makes it a promising candidate for the treatment of a wide variety of diseases - and can also help to compensate for potential side effects of THC.

CBC is also very interesting for dermatology. Initial research results suggest that CBC could be helpful in the treatment of acne, as it regulates sebum production. (5) In addition, its anti-inflammatory properties also come into play with topical application - i.e., application to the skin.

• Pain therapy – support for chronic and neuropathic pain

• Inflammatory diseases – e.g. arthritis or inflammatory bowel diseases

• Mental health – possible effects on depression, stress & anxiety

• Neuroprotection – protection and regeneration of nerve cells (neurogenesis)

• Dermatology – use for acne, skin irritations and excessive sebum production

• Combination therapy – enhancement of the effect of other cannabinoids (entourage effect)

• Preventive application – possible role in protecting against cell damage from oxidative stress

Although THC, CBD, and CBC have certain similarities, the differences are enormous:

CBD Oils from hanfgeflüster

If CBC has so many potential benefits, why isn't it more widely used? This is certainly due in part to the still rather limited research available. Who wants to be a human guinea pig without sufficient scientific evidence?

Another reason might be that CBC is primarily found in young hemp plants. While mature cannabis plants typically have high concentrations of THC or CBD, very young plants often contain significantly more CBC. As the plant grows, the balance shifts, and other cannabinoids (especially CBD and THC) increase.

This insight has practical implications for growers and producers. If the goal is to produce CBC-rich products, plants must be harvested earlier. However, if the focus is on increasing yield and cannabinoid content, harvesting occurs later – when the CBC has long been converted.

CBC is currently often 5 to 20 times more expensive than comparable CBD products. There are various reasons for this. On the one hand, the production of CBC is significantly more complicated than that of CBD. This already starts with the natural concentration in the plant: while CBD is found in large quantities in industrial hemp varieties – often with proportions of 10 to 20% in the flowers – the CBC content is usually only in the range of less than one percent, often significantly lower.

Added to this is the aforementioned reduction in concentration as the plant grows. This means that to obtain the same quantities, much more plant material is needed and – because the plants must be harvested young – therefore many more plants overall, which require space and care. Furthermore, in recent years, breeding has focused almost exclusively on THC- or CBD-rich varieties. High-quality, CBC-rich starting material is scarce.

Technically, the isolation of cannabichromene is also more demanding. CBC is chemically closely related to other cannabinoids such as CBG or CBN, other hemp compounds. To isolate CBC from these, complex purification methods are necessary – such as high-performance liquid chromatography (HPLC). These methods are significantly more cost-intensive than the comparatively simple isolation of CBD through extraction.

Last but not least, the still low interest in CBC plays a role. It is still a niche product, mainly used in studies so far.

Without question: Cannabichromene is a fascinating star in the cannabinoid sky with great therapeutic potential. Initial research suggests that CBC could help with many different symptoms, including pain, inflammation, depression, and acne. It may even promote the formation of new nerve cells.

But despite all the euphoria: Cannabichromene is currently not suitable for everyday use. Research is still in its early stages, production is complex, expensive, and so far hardly standardized. Therefore, pure CBC is currently hardly practical for everyday consumers – not only because of the high price, but also because it is difficult to obtain. Recommendations for standard doses are also lacking, as are practical experience reports.

Those who still want to benefit from the possible advantages can turn to high-quality full-spectrum CBD oils. Here, in addition to many other compounds, CBC is naturally included – and can display its positive effects particularly well thanks to the entourage effect. Subtle, but no less effective.

Medical Disclaimer